DSM completes sale of DSM Elastomers to LANXESS

05-May-2011 - Netherlands

Royal DSM announced that it has completed the sale of DSM elastomers to LANXESS for € 310 million on a cash and debt-free basis. This completes the final stage of the transformation of DSM that began with the divestment program DSM announced in September 2007 as part of its Accelerated Vision 2010 program.

After all regulatory approvals were received DSM and LANXESS completed the transaction effective as per 1 May 2011. The transaction, which was announced on 14 December 2010, will result in a book profit of more than € 100 million for DSM in Q2 2011.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance